Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

AAP President-Elect Testifies Before Senate Committee, Applauds Attention To Children's Benefits
The American Academy of Pediatrics (AAP), a non-profit professional organization of
generic viagra online
PROTECT-1 Phase II/III Induction-Stage Results For ChemoCentryx's Traficet-EN(TM) Presented In Oral Session At DDW 2009 Conference
ChemoCentryx, Inc., announced that Phase II/III clinical data from the company"s PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn"s disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn"s disease demonstrated evidence of clinical efficacy in the reduction of disease severity, as defined by a decrease from baseline in the Crohn"s Disease Activity Index (CDAI) score of at least 70 points over the course of 12 weeks; the more stringent criterion of at least a 100 point decrease in the CDAI score was also met by week 12. In addition, Traficet-EN treatment resulted in colonoscopic evidence of improvement. These data, reported from the Induction Stage of the ongoing PROTECT-1 trial, were presented at Digestive Disease Week (DDW) 2009 in Chicago, IL, by Satish Keshav, M.D., Ph.D., Department of Gastroenterology, John Radcliffe Hospital, Oxford University, in an oral session today.
News of the day
Scientists Open The Door To Future 2-in-1 Breast Cancer Treatments
Scientists from the Breakthrough Breast Cancer Research Centre based at the Institute of Cancer Research have shown for the first time that it is possible for one drug to simultaneously attack cancer cells in two completely different ways. Researchers now hope this discovery could lead to further two-in-one treatments - meaning breast cancer patients could potentially need to take fewer drugs to treat tumours in the future.
Mental Health

Award Nominations Sought For Excellence In Child Abuse Prevention, Oklahoma State Department Of Health

The State Interagency Child Abuse Prevention Task Force and the Office of Child Abuse Prevention (OCAP) at the Oklahoma State Department of Health (OSDH) are accepting nominations for awards to recognize persons and organizations for their demonstrated outstanding commitment and dedication to child abuse prevention in Oklahoma. Awards will be presented at the Annual Child Abuse and Neglect Conference during opening session on Monday, Sept. 21, at the Moore Norman Technology Center in Norman, OK. The four awards to be presented are: 1. The 2009 Outstanding Elected Official Award, which is given to recognize an elected official for distinguished service on behalf of children and families in Oklahoma. 2. The 2009 Marion Jacewitz Award, which is given to recognize an individual in Oklahoma who has made significant contributions to the prevention of child abuse on a statewide level. 3. The 2009 Outstanding Child Abuse Prevention Program Award, which is given to recognize an exceptional community program that has an emphasis in child abuse prevention. 4. The 2009 Mary Ellen Wilson Award, which is given to recognize an individual who has demonstrated outstanding commitment and dedication to child abuse prevention activities in his or her community. Nomination forms may be downloaded directly from the OSDH Web here. Oklahoma State Department of Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009